Catalyst Wire Dossier Catalyst Wire Dossier

BI 187004

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BI 187004, covering 2014-12-23 to 2016-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects [Phase 1]

See pricing